Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors: the 24-week phase 3 RA-BEACON study

Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • O. Zamani
  • B. Combe
  • H.-P. Tony
  • J. S. Burson
  • H. Tahir
  • Mikkel Østergaard
  • B. Augendre-Ferrante
  • A. Beselin
  • E. Larsson
  • M. Casillas
  • J. Smolen
View graph of relations
Original languageEnglish
Article numberPP21
JournalScandinavian Journal of Rheumatology
Issue numberSuppl. 128
Pages (from-to)21-2
Number of pages2
Publication statusPublished - 2016

ID: 49894126